Solid organ transplantation was introduced into the armamentarium of
medical treatments with the first kidney transplant performed 40 years ago.
Since the historic success of kidney transplantation in identical twins, it
has been possible to take advantage of a succession of increasingly effective
immunosuppressive maintenance agents so that organs from nonidentical relatives,
living unrelated individuals, and cadaver donors can be used with excellent
results. Although patients with end-stage kidney failure have the option of
long-term hemodialysis or transplantation, those with progressive heart, liver,
or lung failure will die unless they receive a transplant. Even though dialysis
is available for patients with renal failure, the mortality rates for patients
who remain on dialysis is 30% to 40% higher than that of comparable patients
who receive kidney transplants.1,2
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 11
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.